✦ LIBER ✦

907 ORAL A Phase II study of temsirolimus (CCI-779) in patients with metastatic and/or recurrent endometrial cancer — NCIC CTG IND 160

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of sunitinib in patient

✍ Helen J. Mackay; Anna Tinker; Eric Winquist; Gillian Thomas; Kenneth Swenerton; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 186 KB

408 A phase II study of erlotinib in com

✍ E. Winquist; D. Soulieres; E. Chen; M. Tsao; M. Klein; G. Pond; J. Dancey; E. Ei 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 149 KB

A phase II study of erlotinib (OSI-774)

✍ H. Hirte; A. Oza; K. Swenerton; S.L. Ellard; R. Grimshaw; B. Fisher; M. Tsao; L. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 180 KB

NCIC CTG IND102: a phase II study of the

✍ M. Trudeau; G. Stuart; H. Hirte; P. Drouin; M. Plante; P. Bessette; H. Dulude; D 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 162 KB

A phase II trial of zd0473 in patients w

✍ T.A. Vandenberg; K.A. Gelmon; L. Panasci; M. Crump; B. Norris; A. Tomiak; T. She 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 166 KB

159 Phase II study of OSI-774 given in c

✍ H. Hirte; A. Oza; P. Hoskins; S. Ellard; R. Grimshaw; J. Dubuc-Lissoir; I. Kerr; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 162 KB